Dietary Fructose and the Metabolic Syndrome.
Level 5 - mechanism / opinion, no new human data
Narrative review synthesizing biochemical mechanisms and literature without systematic search methodology
PubMed 31443567 · doi:10.3390/nu11091987
What was done
This paper reviewed recent literature on intestinal and hepatic fructose metabolism and examined evidence linking excessive fructose and sugar-sweetened beverage consumption to markers of the metabolic syndrome.
What was found
The abstract reports no numerical data, effect estimates, or statistical values. It qualitatively states that hepatic fructose metabolism stimulates fructolysis, glycolysis, lipogenesis, and glucose production, contributing to intrahepatic lipid accumulation, hypertriglyceridemia, insulin resistance, and long-term risk for type 2 diabetes and cardiovascular disease.
Why it matters
It outlines the physiological and biochemical pathways through which high intake of refined fructose from soft drinks and processed foods may drive fatty liver disease and dyslipidemia.
Limits
The abstract contains no empirical data or quantitative metrics. As an unsystematic narrative review, it is prone to selection bias and provides no formal quality assessment of the referenced studies.
Cited by
- supports Fructose is significantly sweeter than glucose because it binds more effectively to sweet taste receptors.